| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.58 | 0.04 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |